𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients

✍ Scribed by Chiyomi Egawa; Yasuo Miyoshi; Tetsuya Taguchi; Yasuhiro Tamaki; Shinzaburo Noguchi

Publisher
John Wiley and Sons
Year
2002
Tongue
French
Weight
84 KB
Volume
98
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The prognostic significance of BRCA2 mRNA levels in tumor tissues was studied in sporadic breast cancer patients. BRCA2 mRNA levels were determined by real‐time PCR. Histologic grade III tumors showed significantly (p = 0.001) higher BRCA2 mRNA levels (0.828 ± 0.102 BRCA2/β‐glucuronidase mRNA ratio, mean ± SE) than histologic grade I and II tumors (0.438 ± 0.055) and estrogen receptor (ER)‐negative tumors (0.773 ± 0.102) showed a nonsignificant (p = 0.072) trend toward an increase in BRCA2 mRNA levels compared to ER‐positive tumors (0.541 ± 0.079). Other clinicopathologic parameters, such as menopausal status, lymph node status and tumor size, were not significantly associated with BRCA2 mRNA levels. Patients with high BRCA2 mRNA levels showed a significantly (p = 0.006) lower 5‐year disease free survival rate (63%) than those with low levels (94%). Lymph node metastases, ER negativity and high histologic grade were also significantly (p < 0.05) associated with poor prognosis. Multivariate analysis revealed that BRCA2 mRNA levels were a significant prognostic factor, being independent of the other conventional prognostic factors. Our results suggest that BRCA2 mRNA levels might serve as a clinically useful prognostic factor in breast cancer patients. © 2002 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Expression of maspin predicts poor progn
Expression of maspin predicts poor prognosis in breast-cancer patients
✍ Yoshihisa Umekita; Yasuyo Ohi; Yoshiatsu Sagara; Hiroki Yoshida 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 365 KB

## Abstract The tumor suppressor gene __maspin__ has been reported to inhibit the invasiveness and motility of breast cancer cells. It has been reported that maspin is expressed in normal human mammary epithelial cells but is downregulated during cancer progression, and that p53 could induce maspin

High expression of leptin receptor mRNA
High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels
✍ Yasuo Miyoshi; Tohru Funahashi; Sachiyo Tanaka; Tetsuya Taguchi; Yasuhiro Tamaki 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 330 KB

The association of mRNA expression levels of leptin receptors (long isoform: Lep-R(L) and short isoform: Lep-R(S)) in breast cancer tissue with patient prognosis was studied with special reference to the serum leptin level or the leptin mRNA level in tumor tissue. Lep-R(L), Lep-R(S) and leptin mRNA

JAM-A expression positively correlates w
JAM-A expression positively correlates with poor prognosis in breast cancer patients
✍ Elaine A. McSherry; Sharon F. McGee; Karin Jirstrom; Emma M. Doyle; Donal J. Bre 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 367 KB

## Abstract The cell–cell adhesion protein junctional adhesion molecule‐A (JAM‐A) influences epithelial cell morphology and migration. As migration is required for tumor cell invasion and metastasis, we sought to elucidate the role of JAM‐A in invasive breast cancer. A breast cancer tissue microarr

Overexpression of cyclinD1 predicts for
Overexpression of cyclinD1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients
✍ Yoshihisa Umekita; Yasuyo Ohi; Yoshiatsu Sagara; Hiroki Yoshida 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 94 KB

## Abstract CyclinD1 plays a critical role in regulating cell cycle progression. CyclinD1 mRNA and protein are overexpressed in approximately 50% of primary breast cancer cases. However, its clinical significance as a predictive factor remains unclear. One hundred and seventy‐three female patients

TP53 and MYC gene alterations independen
TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients
✍ Els M.J. J. Berns; Jan G. M. Klijn; Marcel Smid; Iris L. van Staveren; Maxime P. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 792 KB

We intended to establish the frequency of exon-specific TP53 gene alterations and the relation t o patient and tumor characteristics and clinical outcome of patients with breast cancer. By using polymerase chain reaction-single-strand conformation polymorphism analysis (KR-SSCP) and sequencing techn